Healthcare focus FTI is a healthcare-focused venture capital firm with a strong track record in early-stage life science investments in Japan and the US. This indicates potential for strategic partnerships with portfolio startups in therapeutics, diagnostics, digital health, and healthcare services, offering value through operational support and growth capital.

Global network With deep ties to academia, corporates, regulators, and investors in Japan and a global perspective, FTI can facilitate introductions, co-investment opportunities, and cross-border pilots for portfolio companies seeking international expansion and partnerships.

Hands-on support FTI provides hands-on operational and strategic assistance, including business and R&D strategy, partnerships, investor syndication, and management recruitment. This presents upsell opportunities for consulting, recruitment services, and strategic advisory packages to portfolio firms.

Growth readiness Operating a $200M AUM and supporting 30+ portfolio companies signals capacity for follow-on rounds, bridge financing, and syndication opportunities with other investors. Sales conversations can target scaling, regulatory navigation, and international fundraising readiness.

Early-stage focus FTI concentrates on seed and early-stage life science startups across therapeutics, diagnostics, digital health, and healthcare services. This creates opportunities to offer specialized services such as early-stage market access, clinical development planning, and technology scouting services.